Member Info for bonum

cheers mate. Shaping up very nicely for a remarkable microcap success story with only partial penetration into there huge target market Good luck

any climb to 2p will have its slight pull backs which many will see as buying opportunities if there convinced by the investment case & potential for a major rise. Thats why im loading up further for bigger news about chinese contracts & penetration into that market. The rises so far will plae imho especially with a full clearing of any overhang shares & any further buying by the 2p holders Watch LED

just wrote my post & then read yours lol Expecting ATD to rise further tbh and very hopeful for the higher offer price based on whats been discussed here previouisly

I see your looking at LED. It looks like the overhangs nearly spent & should be a very strong move upwards soon. If they get any sort of success with penetration into the china market with there JV partners (let alone the lead position there looking for) itll mutibag many times imho. Speculative early play but great prospects. GL

Bcak from my busines trip and happy to see ATD risen further. Not surprised though & based on the factors weve mentioned here before with us now progressing towards a decision on any takeover. Good luck all especially blowster whose posted some really good company related stuff here

terrible spelling

Just seen the screen and seen whats been happening. Not at all surprised at the rise at all and expect more volume & increases as we approach the decision time. Yesterdays piece in the Evening Standard may is intereseting; "Roche's Hostile Bid for US DNA firm - Roche, the world's third biggest drugmaker, today made a $5.7 billion hostile approach for American gene sequencing firm Illumina, in the latest indication of bog pharma interest in personalised medicine" Thats consistent with the analyst's comment i posted previously about M&A interest in the sector and the willingness to pay premium prices. Asterand are the global leaders in there field and have had the positive contract developments in the last few months. Im abroad on business for a week but will comfortably let ny holding carry as i expect a lot more interest leading upto the final decision on takeover party & price. dyor & gla

This ones about building up the holding levels in the relatively quiet times. With regular progress reports due it wont stay that way for long.

Watch what happens here in the next couple of weeks. You can be sure this is on a lot of peoples radar now and the stable SP is reassuring while we get closer to the actual time for news. Even a few weeks can be a long time for some people when it comes to putting down money in one place. Therell be a lot of funds moving into ATD in the very near term imho

An interesting piece this morning from my news feed. It basically reaffirms the point made earlier about the current trend for M&A in the sector and the premium prices being offered. The point about the 11.9% advance in the fourth quarter alone shows the strengthening of sentiment in the area & another reason i think we could be in for a bidding war here. "The biotechnology sector made impressive progress during the past year. Neither the government debt crisis nor recessionary pressures nor all the turmoil on the currency front were able to stop the Nasdaq Biotech Index from closing the year in positive territory. In the fourth quarter alone, the index advanced 11.9% (in USD), which ultimately led to a gain of 11.8% for the year as a whole. Once again, M&A activity had a major influence on market sentiment towards the biotech sector. The transaction of the year was clearly Gilead's USD 11 bn offer for Pharmasset, which valued the company's shares at a 90% premium to their previous closing price." http://www.moneyam.com/action/news/showArticle?id=4297430

I dont think anyone would say its slowly declining. As Blowster pointed out its been stable in the 4-4.75 range while we wait for the news on the buy out. That should be some time in feb and the factors which support a premium price for the company are still relevant. Although we dont know what that price will be any buyer would secure the global leader in the sector. Probably why theres a number of interested parties vying for a shot at acquiring Asterand. dyor & gl

The historic mine resource estimated by SRK in 2008 is 36.0m tonnes at 0.09% WO3 making it one of the largest tungsten deposits in the western world.

Big drop today and probably due to profit taking from the previous rise. I took an opportunity to add a few more more. Although the drilling campaign at the La Parrilla mine will take 4 months overall the company will be providing progress reports at regualar intervals and the prospects relating to operations & resource price look good. Tungsten has more then doubled in price over the last couple of years & it looks like further price rises are the course for the metal. A good investment at these levels imho

Firming up nicely here and wont be long for news. This is one of those stocks where i would at least have a foothold for the possibility of a buy out at a much higher price. We dont know know what the eventual price will be but some very strong factors for optimism in that regard (global leaders, expanding sector, interest from numerous parties, NCI main supplier & contract extension, recent ONO development). This was selling at 24p not so long ago and theres a current trend in the biotech sector for premium prices to be paid buyouts especially when u have a sector leading company like Asterand. Thats why id keep a foot in this one but other people will have to do there own research & make there own opinions GLa

Have a look at ATD for some near term T/O news & RXP for a major rise in the coming weeks imho Check out the past RNSs for a better picture. GL

Well, looks like the price reacted upwards as opposed to slipping. I managed to get a few K shares on the rise although still some way to go on this. Highly speculative but comfortable with the level of exposure to the stock.

I think well get people retaking positions in the next week or so as we approach the time for any recommended offer to be disclosed. Although we dont know what the offers might be the factors which point towards a premium buy out price are persuasive ones. The price is nice and stable atm so no problem waiting for that RNS.

Sometimes a companys prospects are enhanced through a takeover action & synergies between the parties. Im sure the directors will be well renumerated through any buy out and initial indications about strong interest from numerous parties would suggest to me itll be at a premium price. This was over 24p not so long ago and is still the biggest supplier to America's NCI with the contract having been extended recently as well as the other positive contract developments since the company entered a T/O period. That links in with the analysts view i posted a few days ago about biotech takeovers at premium prices during H1 2012. Im holding on fast to mine and will only be increasing my holding levels towards news.

I like it that way. Nice & stable until further news on the takeover process. It wont be long to wait & i think therell be a lot of others like myself looking to increase there overall holding levels before then. The more i look into the company, sector & recent RNSs, the more i think well get a very hefty premium on any buy out so very comfortable here

have a look at ATD. A much better bet imho but good luck anyway